Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001973141-24-000319
Filing Date
2024-06-24
Accepted
2024-06-24 16:02:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2997
  Complete submission text file 0001973141-24-000319.txt   4557
Mailing Address C/O ALLERGAN 2525 DUPONT DRIVE IRVINE CA 92612
Business Address
PYOTT DAVID E I (Reporting) CIK: 0001051578 (see all company filings)

Type: 144

Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Subject) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36407 | Film No.: 241064211
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)